Question 1

What is the purpose of this imaging technique, and how could it help me?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the PET/CT Whole-body Dynamic Acquisition at FDG to Metastatic Melanoma Under Immunotherapy clinical trial (NCT04272658). Contact the study team or your healthcare provider for specific answers.

Question 2

How will this trial change my current treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the PET/CT Whole-body Dynamic Acquisition at FDG to Metastatic Melanoma Under Immunotherapy clinical trial (NCT04272658). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the risks or side effects of participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the PET/CT Whole-body Dynamic Acquisition at FDG to Metastatic Melanoma Under Immunotherapy clinical trial (NCT04272658). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for scans if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the PET/CT Whole-body Dynamic Acquisition at FDG to Metastatic Melanoma Under Immunotherapy clinical trial (NCT04272658). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if the imaging shows progression or pseudo-progression?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the PET/CT Whole-body Dynamic Acquisition at FDG to Metastatic Melanoma Under Immunotherapy clinical trial (NCT04272658). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there other options available if I choose not to participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the PET/CT Whole-body Dynamic Acquisition at FDG to Metastatic Melanoma Under Immunotherapy clinical trial (NCT04272658). Contact the study team or your healthcare provider for specific answers.

What this study is about